Gastric cancer: Epidemiology, risk factors and prevention strategies
Gastric cancer (GC) is a global health problem, with more than 1 million people newly diagnosed with GC worldwide each year. GC is more prevalent in less developed countries than in more developed countries. About half of all GC cases worldwide occur in East Asia, notably China. Globally, overall in...
Saved in:
Cover
Loading…
Abstract | Gastric cancer (GC) is a global health problem, with more than 1 million people newly diagnosed with GC worldwide each year. GC is more prevalent in less developed countries than in more developed countries. About half of all GC cases worldwide occur in East Asia, notably China. Globally, overall incidence rates of GC are declining, which is potentially attributed to a decrease in
(
) infection and the use of refrigeration to preserve foods rather than salt. GC is a multifactorial disease, and its occurrence and development were impacted by environmental and genetic factors.
infection is the primary risk factor for GC, especially for non-cardia. The prognosis of GC is poor due to stages at the first diagnosis. The 5-year survival rate is less than 10% when patients are diagnosed at an advanced stage, but the rate is as high as 85% if patients are detected at an earlier stage. Endoscopic screening can potentially prevent GC by early diagnosis and early treatment and has been widely adopted in screening programs in East Asian countries, such as Japan and Korea. This review summarizes updated epidemiological aspects, risk factors, and prevention strategies of GC in recent years to help researchers determine the most effective intervention strategies for reducing risk of GC. |
---|---|
AbstractList | Gastric cancer (GC) is a global health problem, with more than 1 million people newly diagnosed with GC worldwide each year. GC is more prevalent in less developed countries than in more developed countries. About half of all GC cases worldwide occur in East Asia, notably China. Globally, overall incidence rates of GC are declining, which is potentially attributed to a decrease in Helicobacter pylori (H. pylori) infection and the use of refrigeration to preserve foods rather than salt. GC is a multifactorial disease, and its occurrence and development were impacted by environmental and genetic factors. H. pylori infection is the primary risk factor for GC, especially for non-cardia. The prognosis of GC is poor due to stages at the first diagnosis. The 5-year survival rate is less than 10% when patients are diagnosed at an advanced stage, but the rate is as high as 85% if patients are detected at an earlier stage. Endoscopic screening can potentially prevent GC by early diagnosis and early treatment and has been widely adopted in screening programs in East Asian countries, such as Japan and Korea. This review summarizes updated epidemiological aspects, risk factors, and prevention strategies of GC in recent years to help researchers determine the most effective intervention strategies for reducing risk of GC.Gastric cancer (GC) is a global health problem, with more than 1 million people newly diagnosed with GC worldwide each year. GC is more prevalent in less developed countries than in more developed countries. About half of all GC cases worldwide occur in East Asia, notably China. Globally, overall incidence rates of GC are declining, which is potentially attributed to a decrease in Helicobacter pylori (H. pylori) infection and the use of refrigeration to preserve foods rather than salt. GC is a multifactorial disease, and its occurrence and development were impacted by environmental and genetic factors. H. pylori infection is the primary risk factor for GC, especially for non-cardia. The prognosis of GC is poor due to stages at the first diagnosis. The 5-year survival rate is less than 10% when patients are diagnosed at an advanced stage, but the rate is as high as 85% if patients are detected at an earlier stage. Endoscopic screening can potentially prevent GC by early diagnosis and early treatment and has been widely adopted in screening programs in East Asian countries, such as Japan and Korea. This review summarizes updated epidemiological aspects, risk factors, and prevention strategies of GC in recent years to help researchers determine the most effective intervention strategies for reducing risk of GC. Gastric cancer (GC) is a global health problem, with more than 1 million people newly diagnosed with GC worldwide each year. GC is more prevalent in less developed countries than in more developed countries. About half of all GC cases worldwide occur in East Asia, notably China. Globally, overall incidence rates of GC are declining, which is potentially attributed to a decrease in ( ) infection and the use of refrigeration to preserve foods rather than salt. GC is a multifactorial disease, and its occurrence and development were impacted by environmental and genetic factors. infection is the primary risk factor for GC, especially for non-cardia. The prognosis of GC is poor due to stages at the first diagnosis. The 5-year survival rate is less than 10% when patients are diagnosed at an advanced stage, but the rate is as high as 85% if patients are detected at an earlier stage. Endoscopic screening can potentially prevent GC by early diagnosis and early treatment and has been widely adopted in screening programs in East Asian countries, such as Japan and Korea. This review summarizes updated epidemiological aspects, risk factors, and prevention strategies of GC in recent years to help researchers determine the most effective intervention strategies for reducing risk of GC. Gastric cancer (GC) is a global health problem, with more than 1 million people newly diagnosed with GC worldwide each year. GC is more prevalent in less developed countries than in more developed countries. About half of all GC cases worldwide occur in East Asia, notably China. Globally, overall incidence rates of GC are declining, which is potentially attributed to a decrease in Helicobacter pylori ( H. pylori ) infection and the use of refrigeration to preserve foods rather than salt. GC is a multifactorial disease, and its occurrence and development were impacted by environmental and genetic factors. H. pylori infection is the primary risk factor for GC, especially for non-cardia. The prognosis of GC is poor due to stages at the first diagnosis. The 5-year survival rate is less than 10% when patients are diagnosed at an advanced stage, but the rate is as high as 85% if patients are detected at an earlier stage. Endoscopic screening can potentially prevent GC by early diagnosis and early treatment and has been widely adopted in screening programs in East Asian countries, such as Japan and Korea. This review summarizes updated epidemiological aspects, risk factors, and prevention strategies of GC in recent years to help researchers determine the most effective intervention strategies for reducing risk of GC. Gastric cancer(GC)is a global health problem,with more than 1 million people newly diagnosed with GC worldwide each year.GC is more prevalent in less developed countries than in more developed countries.About half of all GC cases worldwide occur in East Asia,notably China.Globally,overall incidence rates of GC are declining,which is potentially attributed to a decrease in Helicobacter pylori(H.pylori)infection and the use of refrigeration to preserve foods rather than salt.GC is a multifactorial disease,and its occurrence and development were impacted by environmental and genetic factors.H.pylori infection is the primary risk factor for GC,especially for non-cardia.The prognosis of GC is poor due to stages at the first diagnosis.The 5-year survival rate is less than 10%when patients are diagnosed at an advanced stage,but the rate is as high as 85%if patients are detected at an earlier stage.Endoscopic screening can potentially prevent GC by early diagnosis and early treatment and has been widely adopted in screening programs in East Asian countries,such as Japan and Korea.This review summarizes updated epidemiological aspects,risk factors,and prevention strategies of GC in recent years to help researchers determine the most effective intervention strategies for reducing risk of GC. |
Author | Yang, Lei Li, Qingyu Ying, Xiangji Xu, Zekuan Li, Huichao Lyu, Guoqing Wang, Ning Ji, Jiafu Zhang, Xi Liu, Shuo |
AuthorAffiliation | Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control,Peking University Cancer Hospital & Institute, Beijing 100142, China%Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Beijing 100142, China%Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China%Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210029, China |
AuthorAffiliation_xml | – name: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control,Peking University Cancer Hospital & Institute, Beijing 100142, China%Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Beijing 100142, China%Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China%Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210029, China – name: 2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Beijing 100142, China – name: 4 Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210029, China – name: 1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China – name: 3 Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China |
Author_xml | – sequence: 1 givenname: Lei surname: Yang fullname: Yang, Lei – sequence: 2 givenname: Xiangji surname: Ying fullname: Ying, Xiangji – sequence: 3 givenname: Shuo surname: Liu fullname: Liu, Shuo – sequence: 4 givenname: Guoqing surname: Lyu fullname: Lyu, Guoqing – sequence: 5 givenname: Zekuan surname: Xu fullname: Xu, Zekuan – sequence: 6 givenname: Xi surname: Zhang fullname: Zhang, Xi – sequence: 7 givenname: Huichao surname: Li fullname: Li, Huichao – sequence: 8 givenname: Qingyu surname: Li fullname: Li, Qingyu – sequence: 9 givenname: Ning surname: Wang fullname: Wang, Ning – sequence: 10 givenname: Jiafu surname: Ji fullname: Ji, Jiafu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33446993$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU1v1DAQhi1URD_gL6AckODQhPFH4hghJFpKQarEBc7WrOMEh6y92Nmi7a_H6bYVcOLkkfzMO-_Me0wOfPCWkBcUKkapkK_HyqXkKwoApWpAVAwYVNBUwB-RI6oUL6Hh9CDX98ghOU5pBKhlDfQJOeRciCaDR-TDJaY5OlMY9MbGN8XFxnV27cIUht1pEV36UfRo5hBTgb4rNtFeWz-74Ivch7MdnE1PyeMep2Sf3b0n5NvHi6_nn8qrL5efz99flYYrMZeYp6u2bg0z0kJtWiWFaTrZdEzVK0WlxZ51cqVYTVfYc6C2BSV6IWmv2tbwE_Jur7vZrta2M9lIxElvoltj3OmATv_94913PYRrLaWSjLMs8HIv8At9j37QY9hGny3rmwFvduNySWgAeCZf3Y2K4efWplmvXTJ2mtDbsE2aCZk3EUwt6PM_XT3YuT9yBt7uARNDStH2DwgFfZupHvWSqV4C00tgenGiodG3Vs7-aTduxiWCvKOb_k_kN7WSrAc |
CitedBy_id | crossref_primary_10_3390_bioengineering11100973 crossref_primary_10_1016_j_arabjc_2023_105095 crossref_primary_10_1007_s12293_024_00415_5 crossref_primary_10_31083_j_fbl2910351 crossref_primary_10_32604_or_2023_043807 crossref_primary_10_3389_fmolb_2022_977280 crossref_primary_10_21926_obm_genet_2404272 crossref_primary_10_1186_s12885_024_13401_4 crossref_primary_10_1080_07357907_2022_2126982 crossref_primary_10_1155_2021_8810620 crossref_primary_10_3390_cancers15092639 crossref_primary_10_4253_wjge_v15_i11_658 crossref_primary_10_1016_j_prp_2025_155905 crossref_primary_10_1093_jpp_rgac044 crossref_primary_10_1186_s12885_023_10923_1 crossref_primary_10_1097_MD_0000000000029992 crossref_primary_10_1186_s12935_023_03162_8 crossref_primary_10_1007_s10120_023_01409_x crossref_primary_10_1186_s12876_025_03765_7 crossref_primary_10_1097_CM9_0000000000001795 crossref_primary_10_1007_s12032_023_02174_8 crossref_primary_10_1073_pnas_2123231119 crossref_primary_10_1080_00365521_2023_2286194 crossref_primary_10_3390_nu15173826 crossref_primary_10_4251_wjgo_v16_i3_1084 crossref_primary_10_3390_hygiene3030019 crossref_primary_10_1016_j_gene_2024_149134 crossref_primary_10_1016_j_jddst_2022_103231 crossref_primary_10_1038_s41420_023_01485_z crossref_primary_10_1097_MD_0000000000040601 crossref_primary_10_1080_01635581_2021_2022168 crossref_primary_10_1080_21655979_2022_2072629 crossref_primary_10_51666_fs_2024_4_e9 crossref_primary_10_1002_slct_202404466 crossref_primary_10_1007_s12668_024_01562_2 crossref_primary_10_1007_s12672_024_01451_w crossref_primary_10_1016_j_heliyon_2023_e21064 crossref_primary_10_3390_ijerph18189572 crossref_primary_10_1002_cac2_12367 crossref_primary_10_1038_s43856_024_00655_z crossref_primary_10_3390_cancers14153832 crossref_primary_10_1001_jamanetworkopen_2022_27667 crossref_primary_10_3390_cancers15102778 crossref_primary_10_1007_s00464_024_10748_4 crossref_primary_10_1038_s41420_021_00802_8 crossref_primary_10_1111_jgh_16620 crossref_primary_10_1016_j_ejso_2022_05_025 crossref_primary_10_7759_cureus_31440 crossref_primary_10_1016_j_phymed_2024_155984 crossref_primary_10_1016_j_ijbiomac_2024_130037 crossref_primary_10_1186_s12876_022_02315_9 crossref_primary_10_1016_j_lfs_2023_122316 crossref_primary_10_5306_wjco_v13_i3_186 crossref_primary_10_1016_j_ctarc_2024_100845 crossref_primary_10_1002_anbr_202200148 crossref_primary_10_12944_CRNFSJ_12_1_15 crossref_primary_10_7759_cureus_55902 crossref_primary_10_4103_sjg_sjg_253_22 crossref_primary_10_1016_j_procbio_2023_11_006 crossref_primary_10_1002_ijc_34160 crossref_primary_10_1007_s11427_022_2185_9 crossref_primary_10_1080_00365521_2021_1966092 crossref_primary_10_3390_biom12101459 crossref_primary_10_1038_s41598_024_62494_1 crossref_primary_10_3389_fphar_2023_1063775 crossref_primary_10_3389_fonc_2022_908943 crossref_primary_10_1038_s41392_023_01450_3 crossref_primary_10_4103_abr_abr_185_23 crossref_primary_10_1016_j_compbiomed_2024_108221 crossref_primary_10_1007_s10787_022_01030_x crossref_primary_10_1097_MD_0000000000039527 crossref_primary_10_3390_ijms242116003 crossref_primary_10_1016_j_intimp_2023_111352 crossref_primary_10_1002_btm2_10278 crossref_primary_10_3748_wjg_v29_i15_2222 crossref_primary_10_37699_2308_7005_1_2022_03 crossref_primary_10_1016_j_trim_2023_101793 crossref_primary_10_1038_s41598_022_15839_7 crossref_primary_10_1186_s13244_023_01584_6 crossref_primary_10_1016_j_jep_2024_118812 crossref_primary_10_2147_IJGM_S343306 crossref_primary_10_1007_s11033_022_07667_9 crossref_primary_10_1016_j_tranon_2025_102334 crossref_primary_10_1016_j_biochi_2025_03_002 crossref_primary_10_1016_j_colsurfb_2024_114492 crossref_primary_10_7759_cureus_58482 crossref_primary_10_1007_s00535_024_02209_5 crossref_primary_10_1016_j_tice_2023_102119 crossref_primary_10_1177_15330338221090353 crossref_primary_10_1139_bcb_2023_0331 crossref_primary_10_1186_s13062_023_00449_8 crossref_primary_10_1001_jamanetworkopen_2022_5557 crossref_primary_10_1007_s11033_022_07960_7 crossref_primary_10_1053_j_gastro_2022_03_039 crossref_primary_10_25259_Cytojournal_29_2024 crossref_primary_10_1177_03000605241234558 crossref_primary_10_1016_j_arabjc_2023_105192 crossref_primary_10_1016_j_prp_2022_154086 crossref_primary_10_1097_CJI_0000000000000481 crossref_primary_10_1002_ctm2_1754 crossref_primary_10_3390_cancers14153632 crossref_primary_10_31083_j_fbl2905172 crossref_primary_10_5812_amh_143132 crossref_primary_10_4251_wjgo_v13_i10_1244 crossref_primary_10_1007_s00210_024_03451_7 crossref_primary_10_1016_j_tice_2022_101973 crossref_primary_10_3390_cimb47010055 crossref_primary_10_5946_ce_2023_087 crossref_primary_10_3389_fmolb_2021_720645 crossref_primary_10_3389_fonc_2022_1042248 crossref_primary_10_1007_s10330_022_0551_1 crossref_primary_10_3748_wjg_v28_i12_1187 crossref_primary_10_1016_j_clinre_2022_101913 crossref_primary_10_13105_wjma_v9_i3_257 crossref_primary_10_1186_s40364_021_00340_6 crossref_primary_10_1155_2022_7639968 crossref_primary_10_1186_s12876_021_01928_w crossref_primary_10_1186_s12876_024_03139_5 crossref_primary_10_13048_jkm_24025 crossref_primary_10_1186_s13063_024_08455_5 crossref_primary_10_1080_03036758_2024_2427818 crossref_primary_10_7759_cureus_59508 crossref_primary_10_1007_s12094_022_02809_8 crossref_primary_10_1007_s00464_023_10125_7 crossref_primary_10_1038_s41598_025_90064_6 |
ContentType | Journal Article |
Copyright | Copyright © 2020 Chinese Journal of Cancer Research. All rights reserved. Copyright © Wanfang Data Co. Ltd. All Rights Reserved. Copyright © 2020 Chinese Journal of Cancer Research. All rights reserved. 2020 |
Copyright_xml | – notice: Copyright © 2020 Chinese Journal of Cancer Research. All rights reserved. – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. – notice: Copyright © 2020 Chinese Journal of Cancer Research. All rights reserved. 2020 |
CorporateAuthor | Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Beijing 100142, China Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210029, China |
CorporateAuthor_xml | – name: Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210029, China – name: Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China – name: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China – name: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Beijing 100142, China |
DBID | AAYXX CITATION NPM 7X8 2B. 4A8 92I 93N PSX TCJ 5PM |
DOI | 10.21147/j.issn.1000-9604.2020.06.03 |
DatabaseName | CrossRef PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1993-0631 |
EndPage | 704 |
ExternalDocumentID | PMC7797232 zgazyj202006003 33446993 10_21147_j_issn_1000_9604_2020_06_03 |
Genre | Journal Article |
GrantInformation_xml | – fundername: (This study was supported by Science Foundation of Peking University Cancer Hospital); (and the Beijing Young Talent Program) funderid: (This study was supported by Science Foundation of Peking University Cancer Hospital); (and the Beijing Young Talent Program) |
GroupedDBID | --- -05 -0E -SE -S~ -Y2 .86 0R~ 0VY 1N0 2.D 29B 2JY 2VQ 2~H 30V 4.4 408 40D 5GY 5VR 5VS 6NX 8TC 8UJ 92F 92I 92M 95. 95~ 9D9 9DE AAIAL AANXM AARHV AAYXX AAYZH ABFSG ABJNI ABKZE ABQSL ABTEG ACGFS ACOMO ACSTC ADHKG ADKPE ADQRH ADRFC AENEX AEZWR AFBBN AFHIU AFLOW AFUIB AFWTZ AGGDS AGJBK AGQPQ AHBYD AHKAY AHSBF AHWEU AIXLP ALMA_UNASSIGNED_HOLDINGS AMKLP ASPBG AVWKF AZFZN BA0 BBWZM BGNMA CAG CAJEE CCEZO CHBEP CIEJG CITATION COF CS3 CSCUP CW9 DIK DU5 EBS EJD FA0 FEDTE GX1 HF~ HG6 HMJXF HVGLF HYE HZ~ I~X M4Y MA- N2Q NDZJH NF0 NU0 O9- O93 O9G O9I OK1 OVD P19 P9S PT5 Q-- Q-4 QOK QOS R-E R89 R9I RNI ROL RPM RPX RSV RT5 RZK S1Z S26 S27 S28 S37 S3B SCL SDE SDH SMD SOJ T13 T16 T8U TCJ TEORI TGQ TT1 TUC U1F U1G U2A U5E U5O VC2 WFFXF WK8 ~A9 ~N8 -5E -5G -BR AAXDM ADINQ GQ6 NPM SZN 7X8 2B. 4A8 93N PSX 5PM |
ID | FETCH-LOGICAL-c394t-a7509858c2c7e05c8974c6d76d295b917eaf2d7b9251baf301e8094f471f988c3 |
ISSN | 1000-9604 |
IngestDate | Thu Aug 21 18:30:05 EDT 2025 Thu May 29 04:11:37 EDT 2025 Thu Jul 10 22:59:13 EDT 2025 Thu Jan 02 22:57:12 EST 2025 Tue Jul 01 03:56:58 EDT 2025 Thu Apr 24 23:04:24 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | epidemiology prevention strategy Gastric cancer risk factor |
Language | English |
License | Copyright © 2020 Chinese Journal of Cancer Research. All rights reserved. This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c394t-a7509858c2c7e05c8974c6d76d295b917eaf2d7b9251baf301e8094f471f988c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7797232 |
PMID | 33446993 |
PQID | 2478584293 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7797232 wanfang_journals_zgazyj202006003 proquest_miscellaneous_2478584293 pubmed_primary_33446993 crossref_primary_10_21147_j_issn_1000_9604_2020_06_03 crossref_citationtrail_10_21147_j_issn_1000_9604_2020_06_03 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20201231 |
PublicationDateYYYYMMDD | 2020-12-31 |
PublicationDate_xml | – month: 12 year: 2020 text: 20201231 day: 31 |
PublicationDecade | 2020 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Chinese journal of cancer research |
PublicationTitleAlternate | Chin J Cancer Res |
PublicationTitle_FL | Chinese Journal of Cancer Research |
PublicationYear | 2020 |
Publisher | Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control,Peking University Cancer Hospital & Institute, Beijing 100142, China%Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Beijing 100142, China%Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China%Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210029, China AME Publishing Company |
Publisher_xml | – name: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control,Peking University Cancer Hospital & Institute, Beijing 100142, China%Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Beijing 100142, China%Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China%Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210029, China – name: AME Publishing Company |
SSID | ssj0057501 |
Score | 2.5681617 |
Snippet | Gastric cancer (GC) is a global health problem, with more than 1 million people newly diagnosed with GC worldwide each year. GC is more prevalent in less... Gastric cancer(GC)is a global health problem,with more than 1 million people newly diagnosed with GC worldwide each year.GC is more prevalent in less developed... |
SourceID | pubmedcentral wanfang proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 695 |
SubjectTerms | Review |
Title | Gastric cancer: Epidemiology, risk factors and prevention strategies |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33446993 https://www.proquest.com/docview/2478584293 https://d.wanfangdata.com.cn/periodical/zgazyj202006003 https://pubmed.ncbi.nlm.nih.gov/PMC7797232 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9Mw0IIhEC8IxFf5UpD2BilN7MQJPCHoNqEyXlopPFmO42ydUMrWRGj99dw5jpNuCBVeouoSn9O78_nOuQ9C9oHFTIUq8CWGULG0lL7kMvc1DYoC9nvNJSY4fz2OjxbsSxZlfVtFk11S52O1-WNeyf9wFWDAV8yS_QfOOqQAgN_AX7gCh-G6E48PJXbdUBi5pbTp9zjtG74a6pnI8a6njq0J0EU4ruuuTMTQQsWG2nqthyUlWvRvbF0gd3783R41z_TSgWyHlAyE7uTMgWfLxpyynjYrB7o0oMNmdd5tnvbsIZx0FQ6dusS8dCzvMtSn_XnlFeUYt-00ryptcEEZN1obcY4dzjHOaIqr0n6z6j7QH38TB4vZTMyn2fwmuRWCk2BSvTMX4AN2qGl-7fDdIfvdbO_-Mte2gXLN67gePHv7l6xKoOrALpnfJ_esQ-F9bKXjAbmhq4fks5UMr2Xde28oF289lArPSoUHUuH1UuH1UvGILA6m809Hvu2X4SuashoWGVh_SZTA2uN6EqkEfEUVFzwuwjTKwS_XsgwLnqdg0-ayBNWuE_DuS7BPyjRJFH1M9qpVpZ8SL8CBsHqjIo0ZOJ2SB1SmOVUqiXIWBSPyoSOSULaYPPY0-SHAqTQkBq8SSYw1sScCSSyQxAKjKOmIRG70z7aoyo7jXnf8EKAF8dOWrPSqWYuQcfjjYFvBM09a_jjMlDIWp3iHb3HOPYAV1rfvVMtTU2mdc2zKF46IZ3ks7OJbi82J3Fye4btNwGegz3Z4tefkbr-IXpC9-qLRL8GkrfNXRnJ_A8eCnwo |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gastric+cancer%3A+Epidemiology%2C+risk+factors+and+prevention+strategies&rft.jtitle=Chinese+journal+of+cancer+research&rft.au=Yang%2C+Lei&rft.au=Ying%2C+Xiangji&rft.au=Liu%2C+Shuo&rft.au=Lyu%2C+Guoqing&rft.date=2020-12-31&rft.issn=1000-9604&rft.volume=32&rft.issue=6&rft.spage=695&rft_id=info:doi/10.21147%2Fj.issn.1000-9604.2020.06.03&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgazyj%2Fzgazyj.jpg |